Since November 2018 clinicians can prescribe cannabis-dependent products for medicinal use (CBPMs), but NHS prescriptions are tightly managed and relatively rare. Regular situations in which CBPMs might be regarded consist of critical, remedy-resistant epilepsy and many ache/spasticity conditions — and perhaps then it always needs a specialist hospital consultant to https://helpmehigh.com/